Literature DB >> 18034306

Dynamic testing in Cushing's syndrome.

Blerina Kola1, Ashley B Grossman.   

Abstract

Endogenous Cushing's syndrome (CS) results from chronic exposure to excess glucocorticoids. CS can be ACTH-dependent, caused by ACTH-secreting pituitary or ectopic tumours, or ACTH-independent, caused by cortisol-secreting adrenal tumours. CS can be an extremely difficult diagnosis to make, and assessment will include clinical, biochemical and radiological evaluation. Several screening tests are used for the confirmation of hyper-cortisolaemia and its differentiation from other, more frequent, clinical abnormalities, such as simple obesity, hypertension, depression etc. Other dynamic tests are useful for establishing the aetiology. We have reviewed the current literature on the diagnosis of CS, and based on these data and our own experience, suggest the most useful tests and diagnostic criteria to be used. We conclude that even though laboratory testing is a fundamental part of the investigation of patients with CS, the interpretation of the tests should always be performed with extreme care, as none of the tests has proven fully capable of distinguishing all cases of CS. The biochemical results should be interpreted jointly with the clinical aspects and the radiology findings in a probabilistic matrix, and not as part of a uniform algorithm.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18034306     DOI: 10.1007/s11102-007-0079-x

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  71 in total

1.  Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.

Authors:  E Ghigo; E Arvat; J Ramunni; A Colao; L Gianotti; R Deghenghi; G Lombardi; F Camanni
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

2.  Alterations in serum protein levels in patients with Cushing's syndrome before and after successful treatment.

Authors:  P Putignano; G A Kaltsas; M Korbonits; P J Jenkins; J P Monson; G M Besser; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.

Authors:  E Arvat; R Giordano; J Ramunni; G Arnaldi; A Colao; R Deghenghi; G Lombardi; F Mantero; F Camanni; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

4.  A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.

Authors:  P J Trainer; M Faria; J Newell-Price; P Browne; P Kopelman; D H Coy; G M Besser; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

5.  The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.

Authors:  M Korbonits; G Kaltsas; L A Perry; P Putignano; A B Grossman; G M Besser; P J Trainer
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

Review 6.  Cushing's Syndrome: important issues in diagnosis and management.

Authors:  James W Findling; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-07-25       Impact factor: 5.958

Review 7.  Cushing's syndrome variants secondary to aberrant hormone receptors.

Authors:  André Lacroix; Valérie Baldacchino; Isabelle Bourdeau; Pavel Hamet; Johanne Tremblay
Journal:  Trends Endocrinol Metab       Date:  2004-10       Impact factor: 12.015

8.  Late-night salivary cortisol as a screening test for Cushing's syndrome.

Authors:  H Raff; J L Raff; J W Findling
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

9.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

10.  Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.

Authors:  Blandine Gatta; Olivier Chabre; Christine Cortet; Monique Martinie; Jean-Benoît Corcuff; Patrick Roger; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2007-07-17       Impact factor: 5.958

View more
  4 in total

1.  Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome.

Authors:  Mattia Barbot; Laura Trementino; Marialuisa Zilio; Filippo Ceccato; Nora Albiger; Andrea Daniele; Anna Chiara Frigo; Rodica Mardari; Giuseppe Rolma; Marco Boscaro; Giorgio Arnaldi; Carla Scaroni
Journal:  Pituitary       Date:  2016-10       Impact factor: 4.107

Review 2.  Cushing's disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review.

Authors:  J Lindholm
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 3.  ACTH Antagonists.

Authors:  Adrian John Clark; Rachel Forfar; Mashal Hussain; Jeff Jerman; Ed McIver; Debra Taylor; Li Chan
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-05       Impact factor: 5.555

4.  Indication to dynamic and invasive testing in Cushing's disease according to different neuroradiological findings.

Authors:  E Ferrante; M Barbot; A L Serban; F Ceccato; G Carosi; L Lizzul; E Sala; A Daniele; R Indirli; M Cuman; M Locatelli; R Manara; M Arosio; M Boscaro; G Mantovani; C Scaroni
Journal:  J Endocrinol Invest       Date:  2021-10-26       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.